Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
Shanu F. Roemer(Mayo Clinic), Claudia F. Lucchinetti(Mayo Clinic in Arizona), Dean M. Wingerchuk(WinnMed), Raúl N. Mandler(Mayo Clinic), Hans Lassmann(University of Vienna), Vanda A. Lennon(Mayo Clinic), Eduardo E. Benarroch(Mayo Clinic in Arizona), S J Pittock(Mayo Clinic), Joseph E. Parisi(Mayo Clinic), B. G. Weinshenker(Mayo Clinic), Wolfgang Brück(Universitätsmedizin Göttingen)
Cited by 714
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Multiple Sclerosis
|New England Journal of Medicine|2000|2.9k